Shares of Concord Biotech Limited are likely to remain in focus as the company approaches the record date for its 1:1 bonus share issue. The Ahmedabad-based pharmaceutical company has fixed November 4, 2026, as the date for identifying eligible shareholders.
The company’s board has approved issuing one additional fully paid-up equity share for every existing share held by investors, subject to the necessary statutory and regulatory approvals.
Concord Biotech Bonus Issue Record Date
Investors must hold Concord Biotech shares by November 3, 2026, to qualify for the bonus issue. The record date falls on Wednesday, November 4, and will determine which shareholders are eligible to receive the additional shares.
Also Read:ATF and Commercial LPG Gas Prices Hiked Again: Check New Rates and Impact on Consumers
Also Read :Why Gold and Silver Rate today Crashed : 5 Key Reasons Behind the Massive Fall
Concord Biotech Share Price Performance
Concord Biotech shares ended Friday’s trading session, October 30, at ₹1,245.30 on the BSE, gaining 1.25%. The company’s market capitalisation stood at approximately ₹13,027.86 crore.
The stock has delivered a 1.34% return over the past week. However, its recent performance has been weaker across longer periods.
- Two weeks: Down 6.97%
- One month: Down 9.33%
- One year: Down approximately 14.28%
The stock reached its 52-week high of ₹1,614.05 on August 20, 2026. Its 52-week low stands at ₹987.05, recorded on April 2, 2026.
Despite the recent decline, Concord Biotech shares remain nearly 68% above their IPO issue price of ₹741. The company made its stock market debut in August 2023.
Investors should review the company’s official announcements and consider market risks before making investment decisions.
Also Read:ATF and Commercial LPG Gas Prices Hiked Again: Check New Rates and Impact on Consumers
Also Read :Why Gold and Silver Rate today Crashed : 5 Key Reasons Behind the Massive Fall
By
